We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
Cap. Flow
-$2.03B
Cap. Flow %
-2.36%
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$354M
2
VZ icon
Verizon
VZ
+$307M
3
HCA icon
HCA Healthcare
HCA
+$256M
4
MPC icon
Marathon Petroleum
MPC
+$239M
5
CMCSA icon
Comcast
CMCSA
+$231M

Sector Composition

Rank Sector Weight
1 Healthcare 20.11%
2 Technology 18.25%
3 Consumer Discretionary 14.02%
4 Industrials 10.23%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCFC icon
2026
OceanFirst Financial
OCFC
$1.91B
$246K ﹤0.01%
10,944
ONDK
2027
DELISTED
On Deck Capital, Inc.
ONDK
$246K ﹤0.01%
41,728
+9,469
+29% +$67.3K
ADVM
2028
DELISTED
Adverum Biotechnologies
ADVM
$244K ﹤0.01%
7,739
-6,169
-44% -$251K
CCXI
2029
DELISTED
ChemoCentryx, Inc.
CCXI
$244K ﹤0.01%
22,364
DISCK
2030
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$244K ﹤0.01%
10,572
FLOW
2031
DELISTED
SPX FLOW, Inc.
FLOW
$243K ﹤0.01%
8,002
+1,125
+16% +$42.4K
BSET icon
2032
Bassett Furniture
BSET
$176M
$242K ﹤0.01%
12,069
-49,123
-80% -$995K
ZGNX
2033
DELISTED
Zogenix, Inc.
ZGNX
$241K ﹤0.01%
6,611
-16,610
-72% -$680K
KPTI icon
2034
Karyopharm Therapeutics
KPTI
$48M
$240K ﹤0.01%
1,706
-345
-17% -$58.2K
PK icon
2035
Park Hotels & Resorts
PK
$2.97B
$238K ﹤0.01%
9,156
-4,797
-34% -$142K
NSTG
2036
DELISTED
NanoString Technologies, Inc.
NSTG
$236K ﹤0.01%
15,928
-571
-3% -$9.06K
EE
2037
DELISTED
El Paso Electric Company
EE
$236K ﹤0.01%
+4,698
New +$265K
SHYF
2038
DELISTED
The Shyft Group
SHYF
$235K ﹤0.01%
32,519
-81,811
-72% -$761K
CNR
2039
Core Natural Resources Inc
CNR
$4.45B
$231K ﹤0.01%
7,283
-8,895
-55% -$327K
DS
2040
DELISTED
Drive Shack Inc.
DS
$231K ﹤0.01%
58,928
-52,388
-47% -$259K
GGB icon
2041
Gerdau
GGB
$9.7B
$230K ﹤0.01%
76,991
-21,464
-22% -$69.6K
TISI icon
2042
Team
TISI
$77.7M
$229K ﹤0.01%
+1,563
New +$285K
DQ
2043
Daqo New Energy
DQ
$996M
$227K ﹤0.01%
48,475
AIMC
2044
DELISTED
Altra Industrial Motion Corp
AIMC
$227K ﹤0.01%
+9,033
New +$294K
ITCI
2045
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$226K ﹤0.01%
19,837
-5,275
-21% -$85.2K
AAON icon
2046
Aaon
AAON
$7.77B
$224K ﹤0.01%
9,584
-2,545
-21% -$61.1K
FRBK
2047
DELISTED
Republic First Bancorp Inc
FRBK
$223K ﹤0.01%
37,358
-2,296
-6% -$15.5K
IRMD icon
2048
iRadimed
IRMD
$1.18B
$222K ﹤0.01%
+9,091
New +$244K
TBHC
2049
DELISTED
The Brand House Collective
TBHC
$222K ﹤0.01%
23,304
-20,991
-47% -$204K
VCRA
2050
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$222K ﹤0.01%
+5,653
New +$204K

Similar funds

AQR Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
  • AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
  • AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
  • AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
  • AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
  • AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
  • AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.

Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.